about
The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphataseStructure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active siteStructure of Aspergillus niger epoxide hydrolase at 1.8 A resolution: implications for the structure and function of the mammalian microsomal class of epoxide hydrolasesDirected evolution of an enantioselective epoxide hydrolase: uncovering the source of enantioselectivity at each evolutionary stagePurification, characterization, gene cloning and preliminary X-ray data of the exo-inulinase from Aspergillus awamori.EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.Identification of two epoxide hydrolases in Caenorhabditis elegans that metabolize mammalian lipid signaling molecules.Metabolic detoxification: implications for thresholds.Spectrum of styrene-induced DNA adducts: the relationship to other biomarkers and prospects in human biomonitoring.Pharmacogenetics of modafinil after sleep loss: catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep.Mammalian epoxide hydrolases in xenobiotic metabolism and signalling.Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposesInduction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.The telltale structures of epoxide hydrolases.Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.Cellular expression of human centromere protein C demonstrates a cyclic behavior with highest abundance in the G1 phase.Genetic enhancement of microsomal epoxide hydrolase improves metabolic detoxification but impairs cerebral blood flow regulation.Crystal structures of beta-galactosidase from Penicillium sp. and its complex with galactose.Diversity and biocatalytic potential of epoxide hydrolases identified by genome analysis.Stereochemical features of the hydrolysis of 9,10-epoxystearic acid catalysed by plant and mammalian epoxide hydrolases.cis- and trans-1,2-diphenylaziridines: induction of xenobiotic-metabolizing enzymes in rat liver and mutagenicity in Salmonella typhimurium.Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases.Gene evolution of epoxide hydrolases and recommended nomenclature.Differential subcellular localization of endogenous and transfected soluble epoxide hydrolase in mammalian cells: evidence for isozyme variants.Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase.Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin.The distribution of UDP-glucuronosyltransferases in rat liver parenchymal and nonparenchymal cells.A time-course investigation of vitamin A levels and drug metabolizing enzyme activities in rats following a single treatment with prototypic polychlorinated biphenyls and DDT.Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological monitoring of exposure to styrene.Biochemical characterization of Aspergillus awamori exoinulinase: substrate binding characteristics and regioselectivity of hydrolysis.A fluorometric assay for quantitating phenol sulfotransferase activities in homogenates of cells and tissues.Insights into the catalytic mechanism of human sEH phosphatase by site-directed mutagenesis and LC-MS/MS analysis.Isolation of a putative hydroxyacyl enzyme intermediate of an epoxide hydrolase.Tonic inhibition in principal cells of the amygdala: a central role for α3 subunit-containing GABAA receptors.Evidence for a complex formation between CYP2J5 and mEH in living cells by FRET analysis of membrane protein interaction in the endoplasmic reticulum (FAMPIR).Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase.Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.Acute hepatotoxicity of the polycyclic musk 7-acetyl-1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphtaline (AHTN).
P50
Q24294364-63D4ECA2-BDC4-4FAA-8941-CE6A349E39B9Q24670473-0CBA6874-DD07-420E-94F0-2186F1132E06Q27621371-7FA386E0-02A8-4D83-9EC8-D03FE69C5133Q27655613-97181DC6-0574-4441-91B5-82BB9EAA7DAFQ30671595-C22C32AB-2DCC-4D89-86AC-F63481A7628CQ33288850-3FCAD161-9A6F-478D-94EC-5654A530346BQ33319329-F52D7DE8-3274-454C-9810-77051733F8E4Q33947608-CEE1E51E-601A-43CF-B0ED-D8373A75E4E3Q34712756-88201750-39C6-48A5-809A-D7DFA93618B4Q34889485-57B17F75-7763-4A23-B11D-4481A200E850Q34973653-251F73CA-9356-4DEC-BF03-609AE18BE8FBQ34987815-EA977656-4CB8-4FB2-B8B7-D42D712A7BDFQ35024730-2F5CC51F-D369-46E5-A407-2D1AC244EBFCQ35403688-EDAD917F-BF53-4C41-A880-D46F64786B83Q35620656-5867249D-B59C-4A1C-AB56-EC91349ACA26Q35693584-A0BD0E19-1E1A-41BD-9A2F-0D7CD5B80994Q37332844-6565B255-5204-44D3-8F6D-AFAB6DBDEDA6Q37408068-CA480ADC-DCBF-4420-B218-4A142DB1A5C0Q38335295-ED301547-DDC6-433B-8320-2A181DD4ED68Q41786025-9AC1C6F8-078D-40D9-84C8-4945C35F6948Q42142733-EA5DD129-B19F-4259-9F5D-EEE80771BE09Q42217458-1C7C93BE-7158-4F27-886B-61221C6673ACQ42317759-38165376-2ED6-4531-83DE-37A29E3F6E3AQ42688735-1104DD26-E4EA-4DFE-AB5B-2AB7B861C6B7Q42817822-AAAD8ADC-4737-4227-BB05-D8F20C7ABE21Q42995098-54488434-4410-4328-846B-0D08B94ED904Q43555130-77B1F005-7F6E-48D3-9BCB-8859C28B6717Q43996342-474674ED-7A04-45E6-9EF3-6D1F1FFA55DDQ44087715-96A3094F-DB8C-4BEB-97AB-31539A69E026Q44237761-A8B97B33-2938-4CFD-BE01-474AD1014975Q44551951-C3441463-5079-482F-B30F-BCFF4A21BA26Q44565985-2AA6CE2A-3478-4E4A-8993-F4F2A409B18CQ46384982-8487A5E3-755D-48A6-9A89-EE177E59CDD2Q46478348-89F52C11-409C-4082-BE4D-92E128FC262AQ46746864-B94198F3-DE62-46E7-83AA-58C29E69D849Q47654703-5CD9D3D0-0093-4209-9EC9-3213E4FD3493Q47702795-A2D82F97-FEEE-4780-A334-F8D3C5CCC784Q48196771-421D427B-1533-4F0F-8295-A4441F6582DFQ49336465-56ACB8AF-8541-4240-ACC0-3EB7AD6A78E3Q50655687-1AB6A70E-AB0A-4508-98E0-201A457EAA88
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Michael Arand
@ast
Michael Arand
@en
Michael Arand
@es
Michael Arand
@nl
Michael Arand
@sl
type
label
Michael Arand
@ast
Michael Arand
@en
Michael Arand
@es
Michael Arand
@nl
Michael Arand
@sl
altLabel
Erni
@en
prefLabel
Michael Arand
@ast
Michael Arand
@en
Michael Arand
@es
Michael Arand
@nl
Michael Arand
@sl
P214
P1053
J-3926-2014
P106
P21
P214
P31
P3829
P496
0000-0003-2413-3177
P734
P735
P7859
viaf-1066763